Reports

This indispensable resource examines the worldwide veterinary diagnostics market through the performance of its two key segments: companion animal diagnostics and food animal diagnostics. The World Market for Veterinary Diagnostics, 5th Edition provides detailed analysis of major veterinary disease markets, overall market performance, and future development trends.

Report Highlights:

• Market Overview:
  • In-depth…

Stay ahead in the rapidly evolving cell and gene therapy (CGT) industry with our comprehensive market analysis from Kalorama Information. Cell Therapy and Gene Therapy Markets, 2021-2031 covers market segments, disease epidemiology, and competitive landscapes, providing valuable insights for stakeholders.

Market Segmentation and Analysis:

• Product Segments: Detailed market estimates and forecasts for dermatological, cardiovascular-blood,…

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential,…

Kalorama Information has been at the forefront of covering digital pathology markets alongside related in vitro diagnostic tests for over a decade. Global Digital Pathology Markets, 2022 provides an in-depth analysis of the current market landscape, particularly in light of the ongoing impact of COVID-19.

Key Insights:

• Market Analysis: Detailed market sizing for…

Kalorama Information presents a comprehensive analysis of the evolving global blood screening market in its latest report, World Market for Blood Screening, 2022. This multibillion-dollar market is crucial for ensuring the safety of the blood supply by detecting infectious diseases and conditions. The report provides insights into market dynamics, technological advancements, and regional developments, making…

Unlock valuable insights and data points for strategic business planning with Kalorama Information’s comprehensive report, The World Liquid Biopsy Market, 2021. This report delves into various facets of the liquid biopsy market, providing a detailed analysis that is crucial for stakeholders in the healthcare and diagnostics industry.

Market Highlights:

• Research vs. Clinical Liquid…

The viral vectors market is evolving with advancements in gene therapy and vaccine technologies. New developments are enabling viral vectors to produce stable, non-toxic, and safe therapeutic outcomes. As the industry moves towards standardized and automated manufacturing processes, the potential for viral vectors in treating cancers, genetic diseases, and other conditions continues to grow. Kalorama…

Kalorama Information’s The World Market for Cancer Diagnostics, 2021 offers an in-depth and authoritative analysis of the rapidly evolving cancer testing industry. This comprehensive report provides market sizing, opportunity assessments, and insights into industry mergers and trends, essential for stakeholders and decision-makers in the healthcare sector.

Market Segments:

Explore detailed market data across key…

What is the Size of the IVD Market in 2021?

What Major Trends are Affecting the Market in 2021?

Diagnostic test products have never been more crucial. This report, IVD Market Brief Update, 2021, is an updated analysis of the in vitro diagnostics (IVD) market from Kalorama Information, reflecting the latest data as of Q4…

Using the right laboratory instrumentation at the right time is crucial to the process of drug discovery and development. Life science and analytical instrumentation facilitates R&D involving in a wide variety of workflows throughout early discovery, biomarker identification, clinical trials, translational research, and quality control testing throughout the development of new therapeutic products. The inherent need…

As an in vitro diagnostics (IVD) market, China ranks just behind the large, developed economies of the United States, Western Europe, and Japan. The Chinese healthcare system faces challenges similar to those in less developed countries, alongside burdens common in affluent countries such as diabetes, cardiovascular disease, and aging-related diseases. China’s potential as an IVD…